AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Levetiracetam in Nigeria
4 products registered with NAFDAC — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Leveget Tablet 250 mg_ Tablet | A4-101478 | Getz Pharma Nigeria Limited | active | 26 Aug 2030 |
| Keppra Levetiracetam 250 mg Tablet** Film coated tablet | A4-7333 | GlaxoSmithKline Consumer Nigeria PLC (GSK) | active | 24 May 2028 |
| Keppra Levetiracetam 500 mg** Tablet | A4-7334 | GlaxoSmithKline Consumer Nigeria PLC (GSK) | active | 24 May 2028 |
| Suvitra-500 Tablets Tablet | A4-7250 | Micro Nova Pharmaceuticals Ind Ltd | active | 2 Aug 2026 |
Levetiracetam — NAFDAC Registration Details
NAFDAC (Nigeria) has 4 registered products containing Levetiracetam, of which 4 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Levetiracetam registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.